Furthermore, agomelatine has demonstrated antioxidant properties via the Nrf2/HO-1 pathway in various pathological conditions, such as acute pancreatitis, cerebral ischemia, lung injury, and neuropathic pain [95,96,97,98]. Here, NFE2L2 is linked to Cerebral ischemia.